Navigation Links
EntreMed Presents Multi-Mechanism Results for ENMD-1198 at AACR,Annual Meeting

Antiproliferative and Antiangiogenic Activity Demonstrated in Preclinical Leukemia and Breast Cancer Models

ROCKVILLE, Md., April 17, 2007 /PRNewswire-FirstCall/ -- EntreMed, Inc. , a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and inflammatory diseases, today announced the presentation of preclinical data for its clinical-stage product candidate, ENMD-1198. The data were presented by EntreMed scientists and collaborators during two separate sessions at the American Association for Cancer Research (AACR) Annual Meeting being held this week in Los Angeles, California.

ENMD-1198, a new chemical entity (NCE) based on a modified chemical structure of 2-methoxyestradiol (2ME2), is designed to decrease metabolism while retaining 2ME2's multiple mechanisms of action, including inducing apoptosis, disrupting microtubules, and inhibiting HIF-1 alpha. In preclinical studies, ENMD-1198 has been shown to be an orally active, antimitotic agent that leads to arrest of cell division and apoptosis in tumor cells. ENMD-1198 also exerts antiangiogenic activity that further contributes to its overall antitumor effects.

Results demonstrate that oral administration of ENMD-1198 was well tolerated and produced significant dose-dependent antitumor activity in a preclinical breast tumor model. Histologic staining and evaluation of tumor sections from the breast cancer model demonstrated a decrease in HIF-1 alpha, tumor cell growth (PCNA), and angiogenesis (CD31). HIF-1 alpha is a protein that is upregulated in many human tumors and has been shown to promote tumorigenesis and decrease tumor cell sensitivity to anticancer agents.

In a separate preclinical study, conducted by EntreMed collaborators at the Children's Cancer Institute Australia for Medical Research and the University of New South Wales, ENMD-1198 demonstrated antitumor activity against vinca alkaloid (micro
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Clinical Results From EntreMeds Panzem NCD and Taxol Breast Cancer Study Presented at ASCO
2. Phase 2 Results for EntreMeds Panzem NCD Brain Cancer Study Presented at ASCO
3. EntreMeds Aurora Kinase Inhibitor Induces Tumor Regression in Preclinical Models
4. EntreMed Presents Preclinical Data for MKC-1 in Hematological Cancers
5. EntreMed Presents Multi-Mechanism Antitumor Data for ENMD-1420 in Preclinical Models
6. EntreMed Presents Mechanism Data for Its Three Lead Oncology Compounds
7. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
8. European Society for Medical Oncology (ESMO) Presents Data from the Clinical Trial of MediGenes Cancer-Killing Virus in Press Conference
9. Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Quadramet at International Myeloma Workshop
10. SemBioSys Presents Positive Insulin Data at the American Diabetes Association Conference
11. Tranzyme Pharma Presents Initial Phase IIa Data for its Novel Ghrelin Agonist, TZP-101, in Patients with Diabetic Gastroparesis
Post Your Comments:
(Date:11/21/2014)... Calif. , Nov. 20, 2014  Edwards Lifesciences ... in the science of heart valves and hemodynamic monitoring, ... giving in 2014 to support a strong launch of ... Matters , and to improve the global communities where ... 2014, Edwards, global corporate giving will exceed $8 million, ...
(Date:11/21/2014)... 2014  The acceptance of two abstracts on ... Congress demonstrates continued interest in the Eclipse System, ... control. One of the abstracts, presented by Catherine ... of Urogynecology and Reconstructive Pelvic Surgery at the ... Best Written Abstract on Urogynecology/Pelvic Floor Disorders/Vaginal Surgery. ...
(Date:11/21/2014)... 20, 2014   Wellcentive , the industry ... healthcare organizations, announced today being named one of ... Innovation Award .  Sponsored by Intel, the world ... fourth year, recognizes companies developing leading-edge technology and ... processes. Wellcentive,s Mason Beard ...
Breaking Medicine Technology:Edwards Lifesciences Increases Charitable Giving In 2014 To Support Launch Of Every Heartbeat Matters 2LIFE Study Prominently Featured at Minimally Invasive Gynecology Conference 2LIFE Study Prominently Featured at Minimally Invasive Gynecology Conference 3Wellcentive Named Finalist for 2014 Intel Innovation Award 2Wellcentive Named Finalist for 2014 Intel Innovation Award 3
(Date:11/21/2014)... Recently, TideStore.com, a leading online store offering many ... offer TideStore Thanksgiving Sales . According to the ... provided with big discounts. The special offer is valid ... extra 10% discount with this coupon code: thanks. , ... opportunities to win free gifts. TideStore.com has done much ...
(Date:11/21/2014)... CARE Surrogacy Center in Mexico is ... at the same time enhancing their surrogacy journey with high ... parents across the globe, the company is reporting on its ... zoning in on the skyrocketing costs of surrogacy — and ... over-stressing clinical success rates ? , Fertility clinics ...
(Date:11/21/2014)... TX (PRWEB) November 21, 2014 ... facility at 7am today. The new facility is located ... open 24-7. , “We are pleased to join ... highest quality emergency medical care here,” said Dr. Siddiqi, ... , To celebrate the opening, First Choice ...
(Date:11/21/2014)... Maureen Salamon HealthDay Reporter ... Jobs requiring intellectually challenging tasks may help preserve thinking ... suggests. The researchers compared IQ scores obtained ... with their memory and reasoning scores around age 70. ... jobs appeared to retain sharper thinking even years after ...
(Date:11/21/2014)... (HealthDay News) -- Some people with cochlear implants experience ... when they undergo an MRI scan, a new study ... researchers, about 300,000 people worldwide have cochlear implants, devices ... are deaf or have severe hearing loss. There have ... implants when undergoing MRI. One expert said the ...
Breaking Medicine News(10 mins):Health News:Thanksgiving Sales from TideStore.com 2Health News:CARE Surrogacy Center Reports on its Multiple Measures of Success 2Health News:CARE Surrogacy Center Reports on its Multiple Measures of Success 3Health News:First Choice Emergency Room Opens New Facility in Friendswood, Texas 2Health News:Could Your Job Help Preserve Your Aging Brain? 2Health News:Could Your Job Help Preserve Your Aging Brain? 3Health News:MRI Can Be Painful, Disruptive for People With Cochlear Implants 2
... brain, study suggests , , WEDNESDAY, Aug. 22 (HealthDay News) ... traumatic memories go so deep and linger so long ... shows that a powerful neurochemical called norepinephrine is released ... it also "imprints" an emotional fear tagged to the ...
... it prevented buildup of dangerous tau protein , , TUESDAY, ... combat a protein implicated in Alzheimer,s disease has proven ... protein accumulates into damaging tangles in the memory center ... at the New York University Medical Center (NYUMC). , ...
... , TUESDAY, Aug. 21 (HealthDay News) -- Claims of male-female ... or validation, experts report in the Aug. 22/29 issue of ... A team of researchers in Greece analyzed 77 studies that ... percent) of these claims were decided in advance of the ...
... three-quarters of cases went unnoticed, study found , , TUESDAY, ... one in four children who had high blood pressure ... the dangerous problem is missed. , "Hypertension in children ... a pediatrician, internist and fellow at the Center for ...
... major study finds , , TUESDAY, Aug. 21 (HealthDay News) -- ... cancer and acrylamide, a substance found in many baked and ... subject conducted to date. , "The data are accumulating, and ... to be an important breast cancer risk factor," said study ...
... the behavioral and academic problems associated with Attention Deficit ... by researchers at Lehigh Universitys College of Education. , ... National Institute of Mental Health (NIMH), was the largest ... 5 who have shown significant symptoms of ADHD. It ...
Cached Medicine News:Health News:Study Probes Roots of Fearful Memories 2Health News:Gene Studies of Male-Female Differences Often Flawed 2Health News:Doctors Often Miss High Blood Pressure in Kids 2Health News:Doctors Often Miss High Blood Pressure in Kids 3Health News:Acrylamide Won't Raise Breast Cancer Risk 2Health News:Acrylamide Won't Raise Breast Cancer Risk 3Health News:Acrylamide Won't Raise Breast Cancer Risk 4Health News:Non-medicinal treatment touted for pre-schoolers with ADHD 2Health News:Non-medicinal treatment touted for pre-schoolers with ADHD 3
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: